Work

Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902

Year: 2006

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdl375

Authors: C.M. Rocha-Lima, J.E. Herndon, M.E. Lee, J.N. Atkins, A. Mauer, E. Vokes, M.R. Green

Institutions: University of Miami, Virginia Oncology Associates, University of Chicago, Roper Hospital

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute

Awards: Cancer and Leukemia Group B, Cancer and Leukemia Group B Statistical Center, University of Iowa CALGB Institutional Grant, Southeast Cancer Control Consortium, Inc, Cancer and Leukemia Group B, CANCER AND LEUKEMIA GROUP B: RPMI/SUNYAB, CANCER AND LEUKEMIA GROUP B, Cancer and Leukemia Group B, CANCER AND LEUKEMIA GROUP B, Cancer and Leukemia Group B, GREEN MOUNTAIN ONCOLOGY GROUP, CANCER AND LEUKEMIA GROUP B, Cancer and Leukemia Group B, CANCER CENTER CALGB PARTICIPATION, Cancer and Leukemia Group B, Cancer and Leukemia Group B - The Ohio State University, CANCER AND LEUKEMIA GROUP B

OpenAlex ID: W2126307762

FWCI: 2.061

Cites: 23

Cited by: 39

Related to: 10